The Global Fill-Finish Manufacturing Market is expanding due to rising demand for injectable drugs, driven by biologics and ...

We explore the challenges and opportunities of eco-design in parenteral packaging, from alternative feedstocks and carbon ...

Researchers led by investigators at Mass General Brigham have published valuable information about a rare but serious ...

According to a recent report by Mordor Intelligence, the generic injectables market size is valued at USD 131.68 billion in ...

CorMedix surges on strong DefenCath uptake as sales climb while the Melinta acquisition expands and diversifies its ...

https://www.thehindubusinessline.com/markets/stock-markets/sai-parenterals-buys-746-stake-in-australias-noumed-pharmaceuticals-for-125-crore/article70345384.ece Copy ...

Parenteral nutrition (PN) is a lifesaving means of nutritional support for thousands of hospitalized infants who cannot tolerate normal oral feeding due to the immaturity or surgical removal of the ...

Eris Lifesciences has moved to strengthen its presence in the pharmaceutical manufacturing space with the acquisition of a 30 per cent stake in Swiss Parenterals Ltd for Rs 4.23 billion. The deal ...

Eris Lifesciences is set pick up the remaining 30 per cent stake in its subsidiary Swiss Parenterals Ltd, for a consideration of ₹423 crore. In a development that comes more than a year after it ...

Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

IPO-bound pharmaceutical formulations company Sai Parenteral’s has acquired 74.6% stake in Adelaide-based Noumed Pharmaceuticals for ₹125 crore. With AUD 60 million in revenue, Noumed is a supplier of ...